Bexion Pharmaceuticals
Joyce LaViscount brings over 30 years of pharma experience spanning start-up organizations to Fortune 100 companies with diverse leadership roles across finance, accounting, and operations. She previously served as CFO for Pananvance Therapeutics, a clinical-stage pharma company focused on a novel oncology therapeutic. Her experience includes raising strategic capital to fund corporate development in both private and public company settings. Joyce’s foundation in the industry is based on 20 years of increasing responsibilities with Pfizer/Pharmacia, Bristol-Myers Squibb, and Endo Pharmaceuticals.
This person is not in any offices
Bexion Pharmaceuticals
Bexion Pharmaceuticals is committed to the discovery and clinical development of life-changing oncology treatments. Bexion focuses on helping patients and their families living with cancer, where there is a significant unmet need.